À¯¹æ¾ÏÀÇ »õ·Î¿î Ä¡·á ±âÁØÀ» Á¦½ÃÇÏ´Â ÀþÀº ¸íÀÇ
´ëÇѿܰúÇÐȸ Æò»ýȸ¿øÀÌÀÚ Çѱ¹À¯¹æ¾ÏÇÐȸ, ´ëÇѰ©»ó¼±³»ºÐºñ¿Ü°úÇÐȸ, ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ Á¤È¸¿øÀ¸·Î Ȱµ¿Çϸç, Çѱ¹À¯¹æ¾ÏÇÐȸ ÆíÁýÀ§¿øÈ¸ ºÎÆíÁýÀå°ú ÀÓ»ó½ÃÇèÀ§¿øÈ¸ À§¿øÀ» ¸Ã°í ÀÖ´Ù. À¯¹æ¾ÏÀÇ ¸ÂÃãÇü Ä¡·á, ³»½Ã°æ¡¤·Îº¿¼ö¼ú, Ç׾ϡ¤Ç¥ÀûÄ¡·á ¹ÝÀÀ ¿¹Ãø ¿¬±¸¿¡ ÁýÁßÇϰí ÀÖÀ¸¸ç, ¡®The Breast¡¯ µî ±¹Á¦ÇмúÁö¿¡ ´Ù¼öÀÇ ³í¹®À» °ÔÀçÇß´Ù. 2018³â ±¹Á¦À¯¹æ¾ÏÇÐȸ(GBCC) ¿ì¼öÆ÷½ºÅÍ»ó°ú 2021³â µÎ»ê¿¬°¿Ü°úÇмú»ó°úÀ» ¼ö»óÇß´Ù.
| Á¦ ¸ñ | An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2023 | ¹ßÇ¥Áö | The Breast 72 |
| Á¦ ¸ñ | Hypofractionated Radiotherapy for Early-Stage Breast Cancer: A Propensity Score Matched Analysis | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2022 | ¹ßÇ¥Áö | Journal of Korean Medical Science 37 (8) |
| Á¦ ¸ñ | Combined treatment with anti-HER2/neu and anti-4-1BB monoclonal antibodies induces a synergistic antitumor effect but requires dose optimization to maintain immune memory for protection from lethal rechallenge | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2022 | ¹ßÇ¥Áö | Cancer Immunology, Immunotherapy, 1-12 |
| Á¦ ¸ñ | Synergism of a novel MCL 1 downregulator, acriflavine, with navitoclax in triple negative breast cancer, lung adenocarcinoma and glioblastoma multiforme | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2022 | ¹ßÇ¥Áö | International journal of oncology 60 (1), 1-12 |
| Á¦ ¸ñ | Postpartum Galactocele in Augmented Breast after Using Breast Pump Mimicking Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2021 | ¹ßÇ¥Áö | Journal of the Korean Society of Radiology 82 (6), 1570-1574 |
| Á¦ ¸ñ | Enlightening the immune mechanism of the abscopal effect in a murine HCC model and overcoming the late resistance with Anti-PD-L1 | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2021 | ¹ßÇ¥Áö | International Journal of Radiation Oncology Biology Physics 110 (2), 510-520 |
| Á¦ ¸ñ | Induction of Triple-negative Breast Cancer Cells to Immunogenic Cell Death and Increase Cross-Presentation by Streptomyces sanyensis | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2021 | ¹ßÇ¥Áö | Pharmacognosy Research 13 (3) |

Áß¾Ó´ëÇб³±¤¸íº´¿øÀº KTX±¤¸í¿ª ÀαÙÀÇ 700º´»óÀ» °®Ãá Á¾ÇÕÀÇ·á±â°üÀÌ´Ù. ¾Ïº´¿ø¡¤½ÉÀå³úÇ÷°üº´¿ø¡¤Ã´Ãß¼¾ÅÍ¡¤°üÀý¼¾ÅÍ¡¤È£Èí±â¾Ë·¹¸£±â¼¾ÅÍ¡¤¼Òȱ⼾ÅÍÀÇ 6°³ ÁßÁõŬ·¯½ºÅ͸¦ ¿î¿µÇϰí ÀÖ´Ù. ¼öµµ±Ç ÁßÁõÀÇ·áü°èÀÇ Áß½ÉÀ» ´ã´çÇÏ´Â '¼ö¼ú ÀßÇÏ´Â º´¿ø'À¸·Î °Åµì³ª°í ÀÖÀ¸¸ç, ÀÇ·á±â°üÀÇ µðÁöÅÐ ÀüȯÀ» ¼±µµÇϸç ÃÖ°í¼öÁØÀÇ °æÀï·ÂÀ» È®º¸Çß´Ù.
°æ±âµµ ±¤¸í½Ã ´ö¾È·Î 110